Skip to main content

Advertisement

SpringerLink
Log in

Endocrine complications of thalassemia

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Growth, sexual development, fertility, bone mineral density, diabetes mellitus, hypothyroidism, hypoparathyroidism, and hypoadrenalism are the main issues to be addressed in the long-term follow-up of patients with thalassemia. During childhood, growth may be affected by anemia, and other potential endocrine complications. Puberty is the stage of the maximal growth insult. Beta thalassemia is associated with bone abnormalities characterized by bone marrow expansion of the medullary cavity, and osteopenia with cortical thickening and trabecular coarsening. Good nutrition with adequate vitamins and trace elements intake, along with calcium and vitamin D supplementation, can increase bone density and prevent bone loss. Endocrine abnormalities should be monitored carefully and a thorough endocrine evaluation should be carried out yearly in every patients to detect subclinical endocrinopaties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cooley T.B., Lee P. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans. Am. Pediatr. Soc. 1925, 37: 29–30.

    Google Scholar 

  2. Weatherall D.J. The thalassemias. In: Stamatoyannopoulos G., Nienhuis A.M., Majerus P.H., Varmus H., (Eds.), The molecular basis of blood diseases, ed. 2. W.B. Saunders, Philadelphia, 1994, p. 157.

    Google Scholar 

  3. Olivieri N.F. Medical progress: the (beta)-thalassemias. N. Engl. J. Med. 1999, 341: 99–109.

    Article  CAS  PubMed  Google Scholar 

  4. Cazzola M., Bornga-Pignatti C., Locatelli F., Ponchio L., Beguin Y., De Stefano P. A moderate transfusion regimen may reduce iron loading in (beta)-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion 1997, 37: 135–140.

    Article  CAS  PubMed  Google Scholar 

  5. Olivieri N.F., Brittenham G.M. Iron-chelating therapy and the treatment of thalassemia. Blood 1997, 89: 739–761

    CAS  PubMed  Google Scholar 

  6. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin. Endocrinol. (Oxf.) 1995, 42: 581–586.

    Article  Google Scholar 

  7. Garcia-Mayor R.V., Andrade Olivie A., Fernandez Catalina P., Castro M., Rego Iraeta A., Reparaz A. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study. Horm. Res. 1993, 40: 189–193.

    Article  CAS  PubMed  Google Scholar 

  8. Olivieri N.F., Koren G., Harris J., Khattak S., Freedman M.H., Templeton D.M., Bailey J.D., Reilly B.J. Growth failure and bony changes induced by deferoxamine. Am. J. Pediatr. Hematol. Oncol. 1992, 14: 48–56.

    Article  CAS  PubMed  Google Scholar 

  9. Arcasoy A., Cavdar A., Cin S., Erten J., Babacan E., Gozdasoglu S., Akar N. Effects of zinc supplementation on linear growth in beta-thalassemia (a new approach). Am. J. Hematol. 1987, 24: 127–136.

    Article  CAS  PubMed  Google Scholar 

  10. Theodoridis C., Ladis V., Papatheodorou A., Berdousi H., Palamidou R., Evagelopoulou C., Athanassaki K., Konstantoura O., Kattamis C. Growth and management of short stature in thalassaemia major. Pediatr. Endocrinol. Metab. 1998, 11: 835–844.

    Google Scholar 

  11. Soliman A.T., EI Banna N., Ansari B.M. GH response to provocation and circulating IGF-1 and IGF-binding protein-3 concentrations, the IGF-1 generation test and clinical response to GH therapy in children with beta-thalassaemia. Eur. J. Endocrinol. 1998, 138: 394–400.

    Article  CAS  PubMed  Google Scholar 

  12. Leger L., Girot R., Crosnier H., Postel-Vinay M.C., Rappaport R. Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect. J. Clin. Endocrinol. Metab. 1989, 69: 453–456.

    Article  CAS  PubMed  Google Scholar 

  13. Pintor C., Cella S.G., Manso P., Corda R., Dessi C., Locatelli V., Muller E.E. Impaired growth hormone (GH) response to GHreleasing hormone in thalassemia major. J. Clin. Endocrinol. Metab. 1986, 62: 263–267.

    Article  CAS  PubMed  Google Scholar 

  14. DeLuca G., Maggiolini M., Bria M., Caracciolo M., Giorno A., Salemo M., Marsico S., Lanzino M., Brancati C., Ando S. GH secretion in thalassemia patients with short stature. Horm. Res. 1995, 44: 158–163.

    Article  CAS  PubMed  Google Scholar 

  15. Low L.C., Postel-Vinay M.C., Kwan EX., Cheung P.T. Serum growth hormone (GH) binding protein, IGF-1 and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment. Clin. Endocrinol. (Oxf.) 1998, 48: 641–646.

    Article  CAS  Google Scholar 

  16. Postel-Vinay M.C., Girot R., Leger J, Hocquette J.F., McKelvie P., Amar-Costesec A., Rappaport R. No evidence for a defect in growth hormone binding to liver membranes in thalassemia major. J. Clin. Endocrinol. Metab. 1989, 68: 94–98.

    Article  CAS  PubMed  Google Scholar 

  17. Shehadeh N., Hazani A., Rudolf M.C., Peleg I., Benderly A., Hochberg Z. Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr. Scand. 1990, 79: 790–795.

    Article  CAS  PubMed  Google Scholar 

  18. Katzos G., Papakostantinou-Athanasiadou E., Athanasiou-Metaxa M., Harsoulis F. Growth hormone treatment in short children with beta-thalassemia major. J. Pediatr. Endocrinol. Metab. 2000, 131: 163–170.

    Google Scholar 

  19. Arcasoy A., Ocal G., Kemahli S., Berberoglu M., Yildirmak Y., Canatan D., Akcurin S., Akar N., Uysal Z., Adiyaman P., Cetinkaya E. Recombinant human growth hormone treatment in children with thalassemia major. Pediatr. Int. 1999, 41: 655–661.

    Article  CAS  PubMed  Google Scholar 

  20. Bergeon C., Kovacs K. Pituitary siderosis: a histologic, immunocytologic, and ultrastructural study. Am. J. Pathol. 1978, 9: 295–309.

    Google Scholar 

  21. Berkovitch M., Bistritzer T., Milone S.D., PerIman K., Kucharczyk W., Koren G., Olivieri N.F. Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function. J. Pediatr. Endocrinol. Metab. 2000, 13: 179–184.

    Article  CAS  PubMed  Google Scholar 

  22. Chatterjee R., Katz M., Cox T.F., Porter J.B. Prospective study of the hypothalamic-pituitary axis in thalassaemic patients who developed seconda amenorrhoea. Clin. Endocrinol. (Oxf.) 1993, 39: 287–296.

    Article  CAS  Google Scholar 

  23. Bronspiegel-Weintrob N., Olivieri N.F., Tyler B., Andrews D.F., Freedman M.H., Holland F.J. Effect of age at the start of iron chelation therapy on gonadal function in betathalassemia major. N. Engl. J. Med. 1990, 323: 713–719.

    Article  CAS  PubMed  Google Scholar 

  24. Caruso-Nicoletti M., De Sanctis V., Capra M., Cardinale G., Cuccia L., Di Gregorio F., Filosa A., Galati M.C., Lauriola A., Malizia R., Mangiagli A., Massolo F., Mastrangelo C., Meo A., Messina M.F., Ponzi G., Raiola G., Ruggiero L., Tamborino G., Saviano A. Short stature and body proportion in thalassaemia. J. Pediatr. Endocrinol. Metab. 1998, 11: 811–816.

    PubMed  Google Scholar 

  25. Papanastasiou D.A., Baikousis A., Sdougos G., Ziambaras T., Korovessis P. Correlative analysis of the sagittal profile of the spine in patients with betathalassemia and in healthy persons. J. Spinal Disord. 2000, 13: 113–117.

    Article  CAS  PubMed  Google Scholar 

  26. Korovessis P, Papanastasiou D., Tiniakou M, Beratis N.G. Incidence of scoliosis in beta-thalassemia and follow-up evaluation. Spine 1996, 21: 1798–1801.

    Article  CAS  PubMed  Google Scholar 

  27. de Sanctis V., Stea S., Savarino L., Granchi D., Visentin M., Sprocati M., Govoni R., Pizzoferrato A. Osteochondrodystrophic lesions in chelated thalassemic patients: an histological analysis. Calcif. Tissue Int. 2000, 67: 134–140.

    Article  PubMed  Google Scholar 

  28. Jensen C.E., Tuck S.M., Agnew J.E., Koneru S., Morris R.W., Yardumian A., Prescott E., Hoffbrand A.V., Wonke B. High prevalence of low bone mass in thalassaemia major. Br. J. Haematol. 1998, 103: 911–915.

    Article  CAS  PubMed  Google Scholar 

  29. Soliman A.T., EI Banna N., Abdel Fattah M., EI Zalabani M.M., Ansari B.M. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism 1998, 47: 541–548.

    Article  CAS  PubMed  Google Scholar 

  30. Filosa A., Di Maio S., Saviano A., Vocca S., Esposito G. Can adrenarche influence the degree of osteopenia in thalassemic children? J. Pediatr. Endocrinol. Metab. 1996, 9: 401–406.

    Article  CAS  PubMed  Google Scholar 

  31. Bagni B., Palazzi G., Bagni L., Caporali C., Froefflich W., Casolo A., Caputo C., Rossi S., Garetti E., Pansini F., Corazzari T., De Sanctis V., Massolo F. pQCT (quantitative peripheral tomography) and data evaluation of phosphocalcic metabolism in thalassaemic patients. J. Pediatr. Endocrinol. Metab. 1998, 11: 791–794.

    PubMed  Google Scholar 

  32. Ruggiero L., De Sanctis V. Multicentre study on prevalence of fractures in transfusion-dependent thalassaemic patients. J. Pediatr. Endocrinol. Metab. 1998, 11: 773–778.

    PubMed  Google Scholar 

  33. Vichinsky E.P. The morbidity of bone disease in thalassemia. Ann. Acad. Sci. 1998, 850: 344–348.

    Article  CAS  Google Scholar 

  34. Voskaridou E., Kyrtsonis M.C., Terpos E., Skordili M., Theodoropoulos L., Bergele A., Diamanti E., Kalovidouris A., Loutradi A., Loukopoulos D. Bone resorption is increased in young adults with thalassaemia major. Br. J. Haematol. 2001, 112: 36–41.

    Article  CAS  PubMed  Google Scholar 

  35. Pappas S., Donohue S.M., Denver A.E., Mohamed-Ali V., Goubet S., Yudkin J.S. Glucose intolerance in thalassemia major is related to insulin resistance and hepatic dysfunction. Metabolism 1996, 45: 652–657.

    Article  CAS  PubMed  Google Scholar 

  36. Cavallo-Perin P., Pacini G., Cerutti F., Bessone A., Condo C., Sacchetti L., Piga A., Pagano G. Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia. Metabolism 1995, 44: 281–286.

    Article  CAS  PubMed  Google Scholar 

  37. Dmochowski K., Finegood D.T., Francombe W., Tyler B., Zinman B. Factors determining glucose tolerance in patients with thalassemia major. J. Clin. Endocrinol. Metab. 1993, 77: 478–483.

    CAS  PubMed  Google Scholar 

  38. Arrigo T., Crisaffilli G., Meo A., Sturiale M., Lombardo F., Miceli M., Cucinotta D., De Luca F. Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major. J. Pediatr. Endocrinol. Metab. 1998, 11: 863–866.

    Article  PubMed  Google Scholar 

  39. Theochari M., Loannidou D., Nounopoulos H., Bouloukos A., Papadogiannis M., Katsikari M., Karpathios T., Bartsocas C.S. Ultrasonography of the pancreas, as a function index, in children with beta-thalassemia. J. Pediatr. Endocrinol. Metab. 2000, 13: 303–306.

    Article  CAS  PubMed  Google Scholar 

  40. Midiri M., Lo Casto A., Sparacia G., D’Angelo P., Malizia R., Finazzo M., Montalto G., Solbiati L., Lagalla R., De Maria M. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. Am. J. Roentgenol. 1999, 173: 187–192.

    Article  CAS  Google Scholar 

  41. Alexandrides T., Georgopoulos N., Yarmenitis S., Vagenakis A.G. Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with beta-thalassemia major and iron overload and the subsequent development of hypothyroidism. Eur. J. Endocrinol. 2000, 143: 319–325.

    Article  CAS  PubMed  Google Scholar 

  42. Mariotti S., Loviselli A., Murenu S., Sau F., Valentino L., Mandas A., Vacquer S., Martino E., Balestrieri A., Lai M.E. High prevalence of thyroid dysfunction in adult patients with beta-thalassernia major submitted to amiodarone treatment. J. Endocrinol. Invest. 1999, 22: 55–63.

    CAS  PubMed  Google Scholar 

  43. Klein I., Ojamaa K. Mechanisms of disease: thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 344: 551–558.

    Article  Google Scholar 

  44. Even L., Bader T., Hochbeg Z. Diurnal variations of serum calcium, phosphorus and PTH in the diagnosis of hypoparathyroidism. Pediatr. Res. (abstract) p. 3–141, 2001.

    Google Scholar 

  45. Sklar C.A., Lew L.Q., Yoon O.D.J., David R. Adrenal function in thalassemia major following long-term treatment with multiple transfusions and chelation therapy. Evidence for dissociation of cortisol and adrenal androgen secretion. Am. J. Dis. Child. 1987, 141: 327–330.

    Article  CAS  PubMed  Google Scholar 

  46. Pasqualetti P., Colantonio D., Collacciani A., Casale R., Natali G. Circadian pattern of circulating plasma ACTH, cortisol, and aldosterone in patients with beta-thalassemia. Acta Endocrinol. (Copenh.) 1990, 123: 174–178.

    CAS  Google Scholar 

  47. Cohen A., van Lint M.T., Uderzo C., Rovelli A., Lavagetto A., Vitale V., Morchio A., Locasciulli A., Bacigalupo A., Romano C. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood. Bone Marrow Transplant. 1995, 15: 343–348.

    CAS  PubMed  Google Scholar 

  48. De Simone M., Olioso P., Di Bartolomeo P., Di Girolamo G., Farello G., Palumbo M., Papalinetti G., Bavaro P., Angrilli F., Torlontano G., et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant. 1995, 15: 227–233.

    PubMed  Google Scholar 

  49. De Simone M., Di Bartolomeo P., Olioso P., Di Girolamo G., Palumbo M., Farello G., Aconito P., Papalinetti G., Bavaro P., Criscione S. Growth after recombinant human growth hormone (rhGH) treatment in transplanted thalassemic patients. Bone Marrow Transplant. 1997, 20: 567–573.

    Article  PubMed  Google Scholar 

  50. De Sanctis V., Galimberti M., Lucarelli G., Angelucci E., Ughi M., Baronciani D., Polchi P., Giardini C., Bagni B., Vullo C. Pubertal development in thalassaemic patients after allogenic bone marrow transplantation. Eur. J. Pediatr. 1993, 152: 993–997.

    Article  PubMed  Google Scholar 

  51. De Sanctis V., Galimberti M., Lucarelli G., Angelucci E., Ughi M., Baronciani D., Polchi P., Giardini C., Vullo C., Bagni B. Gonadal function in long term survivors with B thalassemia major following bone marrow transplantation. Bone Marrow Transplant. 1993, 12: 104.

    PubMed  Google Scholar 

  52. Galimberti M., De Sanctis V., Lucarelli G., Polchi P., Angelucci E., Baronciani D., Giardini C., Erer B., Gaziev J., Balducci R., et al. Pancreatic beta-cell function before and after bone marrow transplantation for thalassemia. Bone Marrow Transplant. 1993, 12: 102–103.

    PubMed  Google Scholar 

  53. Cao A., Galanello R., Rosatelli M.C. Prenatal diagnosis and screening of the haemoglobinopathies. Baillieres Clin. Haematol. 1998, 11: 215–238.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Rambam Medical Center, P.O. Box 9602, Haifa, 31096, Israel

    D. Tiosano & Z. Hochberg

Authors
  1. D. Tiosano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. Hochberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Tiosano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tiosano, D., Hochberg, Z. Endocrine complications of thalassemia. J Endocrinol Invest 24, 716–723 (2001). https://doi.org/10.1007/BF03343916

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343916

Key-words

Search

Navigation